Barclays
AST

Barclays’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Barclays’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-128
Closed -$1K – 7463
2015
Q2 		$1K Hold
128
– – ﹤0.01% 6986
2015
Q1 		$1K Sell
128
-92
-42% -$456 ﹤0.01% 7037
2014
Q4 		$1K Buy
+220
New +$886 ﹤0.01% 7214

Barclays's AST Position: Q1 2019 in Review

Barclays sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 53 shares.

Barclays first reported a position in AST in Q4 2014 and held it in 17 quarters. The position peaked at $11K in Q4 2017. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Barclays reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Barclays sold 53 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
  • Barclays first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 17 quarters.
  • Barclays's Asterias Biotherapeutics Inc. Series A position peaked at $11K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.